Attovia Therapeutics, Inc.
ATTO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002058707
In the last 90 days, Attovia Therapeutics, Inc. insiders filed 5 open-market purchases and 1 sale; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of ATTO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Attovia Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 13D | 13.50%6.15M shares | New | Aug 11, 20261 filing | Aug 11, 2026 | SEC |
| Deep Track Capital, LP | 13G | 7.45%3.21M shares | New | Aug 12, 20261 filing | Aug 12, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Attovia Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 20264:02 PM ET | Deep Track Capital, LPand 2 others | 13G | 7.45%3.21M shares | New | Aug 5, 2026 | SEC |
| Aug 11, 20265:08 PM ET | Frazier Life Sciences Public Fund, L.P.and 8 others | 13D | 13.50%6.15M shares | New | Aug 6, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Attovia Therapeutics, Inc. shares.
No Form 144 notices for Attovia Therapeutics, Inc. are on file.